Hereditary gynecological cancer in the genomic era of medicine

Descripción del Articulo

Cancer is a genetic disease caused by accumulation of sporadic genetic changes in the tumor tissue, generally after the age of 50. However, 10% to 30% of cases occur before the age of 50, some have a family history of cancer and may have inherited genetic changes that are transmitted from generation...

Descripción completa

Detalles Bibliográficos
Autores: Sullcahuaman Allende, Yasser C., Loarte Villarreal, Miluska, Torres Loarte, Mariela
Formato: artículo
Fecha de Publicación:2018
Institución:Sociedad Peruana de Obstetricia y Ginecología
Repositorio:Revista Peruana de Ginecología y Obstetricia
Lenguaje:español
OAI Identifier:oai:ginecologiayobstetricia.pe:article/2112
Enlace del recurso:https://ginecologiayobstetricia.pe/index.php/RPGO/article/view/2112
Nivel de acceso:acceso abierto
id REVSPOG_826f56c4a1311321b90e5d4b44c67d8e
oai_identifier_str oai:ginecologiayobstetricia.pe:article/2112
network_acronym_str REVSPOG
network_name_str Revista Peruana de Ginecología y Obstetricia
repository_id_str .
spelling Hereditary gynecological cancer in the genomic era of medicineCáncer ginecológico hereditario en la era de la medicina genómicaSullcahuaman Allende, Yasser C.Loarte Villarreal, MiluskaTorres Loarte, MarielaCancer is a genetic disease caused by accumulation of sporadic genetic changes in the tumor tissue, generally after the age of 50. However, 10% to 30% of cases occur before the age of 50, some have a family history of cancer and may have inherited genetic changes that are transmitted from generation to generation and are present since conception. The number of genes identified is more than 80 related to approximately 200 genetic syndromes of predisposition to cancer. The importance of detecting these syndromes in patients and their families is because it allows an accurate diagnosis and prediction of risks and specific controls for each person and family, avoiding illness and death in many cases.El cáncer es una enfermedad genética producto de la acumulación de cambios genéticos esporádicos en el tejido tumoral. Generalmente se presenta después de los 50 años. Sin embargo, un 10% a 30% de los casos ocurren antes de los 50 años, algunos tienen historia familiar de cáncer y podrían presentar cambios genéticos hereditarios que se transmiten de generación en generación y están presentes desde la concepción. El número de genes que se han identificado son más de 80 relacionados con aproximadamente 200 síndromes genéticos de predisposición al cáncer. La importancia de detectar estos síndromes en los pacientes y familias se debe a que nos permite hacer un diagnóstico preciso, predicción de los riesgos y controles específicos para cada persona y familia, evitando la enfermedad y muerte en muchos casos.Sociedad Peruana de Obstetricia y Ginecología2018-09-28info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://ginecologiayobstetricia.pe/index.php/RPGO/article/view/211210.31403/rpgo.v64i2112The Peruvian Journal of Gynecology and Obstetrics ; Vol. 64 No. 3 (2018); 461-468Revista Peruana de Ginecología y Obstetricia; Vol. 64 Núm. 3 (2018); 461-4682304-51322304-5124reponame:Revista Peruana de Ginecología y Obstetriciainstname:Sociedad Peruana de Obstetricia y Ginecologíainstacron:SPOGspahttps://ginecologiayobstetricia.pe/index.php/RPGO/article/view/2112/pdfDerechos de autor 2018 Revista Peruana de Ginecología y Obstetriciainfo:eu-repo/semantics/openAccessoai:ginecologiayobstetricia.pe:article/21122026-01-12T16:59:16Z
dc.title.none.fl_str_mv Hereditary gynecological cancer in the genomic era of medicine
Cáncer ginecológico hereditario en la era de la medicina genómica
title Hereditary gynecological cancer in the genomic era of medicine
spellingShingle Hereditary gynecological cancer in the genomic era of medicine
Sullcahuaman Allende, Yasser C.
title_short Hereditary gynecological cancer in the genomic era of medicine
title_full Hereditary gynecological cancer in the genomic era of medicine
title_fullStr Hereditary gynecological cancer in the genomic era of medicine
title_full_unstemmed Hereditary gynecological cancer in the genomic era of medicine
title_sort Hereditary gynecological cancer in the genomic era of medicine
dc.creator.none.fl_str_mv Sullcahuaman Allende, Yasser C.
Loarte Villarreal, Miluska
Torres Loarte, Mariela
author Sullcahuaman Allende, Yasser C.
author_facet Sullcahuaman Allende, Yasser C.
Loarte Villarreal, Miluska
Torres Loarte, Mariela
author_role author
author2 Loarte Villarreal, Miluska
Torres Loarte, Mariela
author2_role author
author
description Cancer is a genetic disease caused by accumulation of sporadic genetic changes in the tumor tissue, generally after the age of 50. However, 10% to 30% of cases occur before the age of 50, some have a family history of cancer and may have inherited genetic changes that are transmitted from generation to generation and are present since conception. The number of genes identified is more than 80 related to approximately 200 genetic syndromes of predisposition to cancer. The importance of detecting these syndromes in patients and their families is because it allows an accurate diagnosis and prediction of risks and specific controls for each person and family, avoiding illness and death in many cases.
publishDate 2018
dc.date.none.fl_str_mv 2018-09-28
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://ginecologiayobstetricia.pe/index.php/RPGO/article/view/2112
10.31403/rpgo.v64i2112
url https://ginecologiayobstetricia.pe/index.php/RPGO/article/view/2112
identifier_str_mv 10.31403/rpgo.v64i2112
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://ginecologiayobstetricia.pe/index.php/RPGO/article/view/2112/pdf
dc.rights.none.fl_str_mv Derechos de autor 2018 Revista Peruana de Ginecología y Obstetricia
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Derechos de autor 2018 Revista Peruana de Ginecología y Obstetricia
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Sociedad Peruana de Obstetricia y Ginecología
publisher.none.fl_str_mv Sociedad Peruana de Obstetricia y Ginecología
dc.source.none.fl_str_mv The Peruvian Journal of Gynecology and Obstetrics ; Vol. 64 No. 3 (2018); 461-468
Revista Peruana de Ginecología y Obstetricia; Vol. 64 Núm. 3 (2018); 461-468
2304-5132
2304-5124
reponame:Revista Peruana de Ginecología y Obstetricia
instname:Sociedad Peruana de Obstetricia y Ginecología
instacron:SPOG
instname_str Sociedad Peruana de Obstetricia y Ginecología
instacron_str SPOG
institution SPOG
reponame_str Revista Peruana de Ginecología y Obstetricia
collection Revista Peruana de Ginecología y Obstetricia
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1868078734327676928
score 13.408945
Hereditary gynecological cancer in the genomic era of medicine
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).

Ejemplares Similares